It has been shown that antisense mutations in the CLU gene, resulting in the silencing of gene expression, may increase the chemosensitivity of prostate cancer cells, which is probably caused by blocking the antiapoptotic properties of clusterin [16]. This evidence concerns the gene CLU and Familial prostate cancer.